Tumor Lysis Syndrome NCLEX Questions With Rationales
What it is
Tumor lysis syndrome (TLS) is a potentially life-threatening oncologic emergency caused by rapid destruction of cancer cells, usually following chemotherapy. The breakdown releases intracellular potassium, phosphate, and nucleic acids into the bloodstream, increasing uric acid production. TLS occurs most frequently in clients with rapidly proliferating hematologic malignancies, particularly acute leukemia and aggressive lymphoma with high tumor burden.
What the NCLEX focuses on
- TLS most commonly develops within 72 hours after chemotherapy begins, although spontaneous TLS can occur before treatment.
- Hyperkalemia results from intracellular potassium release and can cause life-threatening cardiac dysrhythmias and cardiac arrest.
- Hyperphosphatemia occurs when phosphate is released from destroyed tumor cells.
- Secondary hypocalcemia develops because circulating phosphate binds calcium, potentially causing tetany, muscle spasms, seizures, and cardiac abnormalities.
- Hyperuricemia develops when nucleic acids are metabolized into uric acid, which can crystallize in renal tubules and cause acute kidney injury.
- Clinical manifestations include nausea, vomiting, muscle cramps, weakness, lethargy, decreased urine output, and altered mental status.
- Clients with acute lymphoblastic leukemia, acute myeloid leukemia, Burkitt lymphoma, and bulky aggressive lymphomas require careful risk assessment.
- Allopurinol inhibits the formation of new uric acid but does not rapidly remove uric acid already present in the bloodstream.
- Rasburicase converts existing uric acid into the more soluble compound allantoin and is contraindicated in clients with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Priority nursing actions
- Assess the client's cardiac and neurological status, vital signs, hydration status, and urine output.
- Initiate continuous cardiac monitoring when TLS is suspected or significant electrolyte abnormalities are present.
- Administer prescribed IV isotonic fluids to maintain renal perfusion and promote urinary elimination, while monitoring for fluid overload.
- Monitor potassium, phosphorus, calcium, uric acid, blood urea nitrogen, and creatinine frequently. High-risk clients may require laboratory monitoring every 4 to 6 hours.
- Administer prescribed allopurinol or rasburicase and promptly report worsening electrolyte abnormalities or declining renal function.
- For severe hyperkalemia, anticipate prescribed IV calcium for cardiac membrane stabilization when indicated, followed by insulin with dextrose to shift potassium intracellularly and additional potassium-lowering treatment as ordered. Prepare for dialysis when indicated.
Numbers to know
| Value | Number | Why it matters |
|---|---|---|
| Typical onset | Within 72 hours | Most cases develop shortly after chemotherapy begins. |
| Potassium | Greater than 6 mEq/L | Associated with hyperkalemia and potentially life-threatening dysrhythmias. |
| Phosphorus | Greater than 6.5 mg/dL | Indicates hyperphosphatemia in adults. |
| Uric acid | Greater than 8 mg/dL | Associated with hyperuricemia and uric acid nephropathy. |
| Calcium | Less than 7 mg/dL | Indicates significant hypocalcemia, which can cause tetany and seizures. |
| Laboratory monitoring | Every 4 to 6 hours | Recommended for high-risk clients receiving antitumor therapy. |
These laboratory thresholds are diagnostic reference values, not independent confirmation of TLS. Laboratory diagnosis requires assessment of the overall pattern and changes from baseline.
Common exam traps
- Choosing allopurinol to rapidly lower existing uric acid: wrong because it prevents new uric acid formation but does not remove existing uric acid.
- Choosing routine calcium replacement for asymptomatic hypocalcemia: wrong because additional calcium can promote calcium-phosphate deposition and worsen renal injury.
- Choosing rasburicase for a client with G6PD deficiency: wrong because it can cause severe hemolysis and methemoglobinemia.
- Choosing urine alkalinization with sodium bicarbonate as routine prevention: wrong because it can promote calcium-phosphate precipitation in renal tubules.
What to teach
- Explain the importance of prescribed IV hydration before and during chemotherapy.
- Teach the client to report muscle cramps, tingling, weakness, palpitations, nausea, and reduced urine output promptly.
- Explain that frequent blood tests and cardiac monitoring help identify dangerous electrolyte changes.
- Encourage adherence to prescribed medications and fluid recommendations.
- Explain that early recognition and treatment help prevent kidney injury, seizures, and cardiac complications.
2 NCLEX questions with rationales on this topic
From the NCLEXPace question bank. Choose your answer first, then open the correct answer and the full rationale under each question.
A client with Burkitt lymphoma received the first dose of chemotherapy 36 hours ago and now reports muscle cramps and tingling around the mouth. Which set of laboratory results should the nurse expect?
- A. Potassium 3.1 mEq/L, phosphorus 2.0 mg/dL, calcium 11.8 mg/dL, uric acid 3.2 mg/dL
- B. Potassium 6.3 mEq/L, phosphorus 7.4 mg/dL, calcium 7.1 mg/dL, uric acid 12.5 mg/dL
- C. Potassium 6.1 mEq/L, phosphorus 2.2 mg/dL, calcium 12.0 mg/dL, uric acid 11.9 mg/dL
- D. Potassium 3.0 mEq/L, phosphorus 7.2 mg/dL, calcium 7.3 mg/dL, uric acid 3.0 mg/dL
Show the correct answer and rationale
Correct answer:
- Potassium 6.3 mEq/L, phosphorus 7.4 mg/dL, calcium 7.1 mg/dL, uric acid 12.5 mg/dL
Rationale
Overview
- Definition: Tumor lysis syndrome is a metabolic emergency caused by rapid destruction of malignant cells with release of their contents into the blood.
- Cause: Destroyed cells release potassium, phosphate, and nucleic acids; the nucleic acids are metabolized to uric acid.
- Findings: Phosphate binds calcium and lowers the serum calcium level, which causes muscle cramps, perioral tingling, tetany, and seizures.
- Timing: Most cases develop within 72 hours after chemotherapy begins.
Nursing key points
- Expect high potassium, high phosphorus, high uric acid, and low calcium.
- Monitor electrolytes, uric acid, and creatinine frequently in high-risk clients.
- Place the client on a cardiac monitor when the potassium level is elevated.
- Report muscle cramps, tingling, decreased urine output, and dysrhythmias promptly.
- Maintain the prescribed IV hydration and uric acid-lowering medication.
Answer analysis
| Laboratory results | Rationale |
|---|---|
| Potassium 6.3 mEq/L, phosphorus 7.4 mg/dL, calcium 7.1 mg/dL, uric acid 12.5 mg/dL | Correct. Cell breakdown raises potassium, phosphorus, and uric acid, and the phosphate binds calcium and lowers it. |
| Potassium 3.1 mEq/L, phosphorus 2.0 mg/dL, calcium 11.8 mg/dL, uric acid 3.2 mg/dL | Not correct. Every value moves in the direction opposite to tumor lysis syndrome. |
| Potassium 6.1 mEq/L, phosphorus 2.2 mg/dL, calcium 12.0 mg/dL, uric acid 11.9 mg/dL | Not correct. Phosphorus rises and calcium falls in tumor lysis syndrome. |
| Potassium 3.0 mEq/L, phosphorus 7.2 mg/dL, calcium 7.3 mg/dL, uric acid 3.0 mg/dL | Not correct. Potassium and uric acid rise when tumor cells break down. |
A client with newly diagnosed acute lymphoblastic leukemia and a high tumor burden is scheduled to begin chemotherapy. The healthcare provider identifies a high risk for tumor lysis syndrome. Which nursing interventions support prevention and early detection of this complication? Select all that apply.
- A. Administer the prescribed IV fluids before chemotherapy begins.
- B. Give the prescribed allopurinol starting before chemotherapy.
- C. Offer orange juice and bananas to replace potassium lost with treatment.
- D. Check that G6PD testing is negative before giving prescribed rasburicase.
- E. Monitor potassium, phosphorus, calcium, uric acid, and creatinine every 4 to 6 hours as prescribed.
- F. Give prescribed calcium carbonate with meals to prevent a low calcium level.
Show the correct answer and rationale
Correct answers:
- Administer the prescribed IV fluids before chemotherapy begins.
- Give the prescribed allopurinol starting before chemotherapy.
- Check that G6PD testing is negative before giving prescribed rasburicase.
- Monitor potassium, phosphorus, calcium, uric acid, and creatinine every 4 to 6 hours as prescribed.
Rationale
Overview
- Definition: Tumor lysis syndrome is a potentially life-threatening complication of rapid malignant cell destruction.
- Cause: Rapid breakdown of tumor cells releases potassium, phosphate, and nucleic acids, increasing the risk of electrolyte disturbances and renal injury.
- Risk factors: Acute lymphoblastic leukemia with high tumor burden and sensitivity to chemotherapy increases the risk of tumor lysis syndrome.
- Prevention: Preventive management includes IV hydration, appropriate uric acid-lowering medication, and frequent monitoring of laboratory values and clinical status.
Nursing key points
- Begin prescribed IV hydration before chemotherapy in high-risk clients.
- Allopurinol prevents the formation of additional uric acid.
- Rasburicase converts existing uric acid to allantoin and is contraindicated in G6PD deficiency.
- Monitor electrolytes, uric acid, creatinine, urine output, and cardiac rhythm.
- Avoid added potassium, and do not give calcium for a low level that causes no symptoms.
Answer analysis
| Nursing intervention | Rationale |
|---|---|
| Administer the prescribed IV fluids before chemotherapy begins. | Correct. IV hydration supports renal perfusion and promotes excretion of uric acid, potassium, and phosphate. |
| Give the prescribed allopurinol starting before chemotherapy. | Correct. Allopurinol inhibits xanthine oxidase and prevents the formation of new uric acid. |
| Offer orange juice and bananas to replace potassium lost with treatment. | Not correct. Tumor cell breakdown raises the potassium level, so high-potassium foods are avoided. |
| Check that G6PD testing is negative before giving prescribed rasburicase. | Correct. Rasburicase can cause hemolysis and methemoglobinemia in a client with G6PD deficiency. |
| Monitor potassium, phosphorus, calcium, uric acid, and creatinine every 4 to 6 hours as prescribed. | Correct. Frequent laboratory monitoring detects electrolyte changes and declining renal function early. |
| Give prescribed calcium carbonate with meals to prevent a low calcium level. | Not correct. Calcium is not given to prevent hypocalcemia because it can combine with the high phosphate and deposit in the kidneys. |
The NCLEXPace bank has 3,200+ NCLEX questions with full rationales, sorted by topic, with your progress tracked as you practice. Create your account to start.
Create Account →More topics in Medical-Surgical
Lyme Disease NCLEX Questions With RationalesCovers Lyme disease stages, clinical manifestations, doxycycline treatment, tick removal, nursing priorities, and prevention.Influenza NCLEX Questions With RationalesReviews seasonal influenza symptoms, high-risk groups, antiviral treatment, isolation, vaccination, complications, and nursing care.Atopic Dermatitis (Eczema) NCLEX Questions With RationalesReviews childhood eczema manifestations, age-related distribution, triggers, skin care, topical medications, infection prevention, and parent education.Sources
- National Library of Medicine, NCBI Bookshelf. Tumor Lysis Syndrome. 2024.
- Merck Manual Professional Edition. Management of Adverse Effects of Cancer Therapy. 2026.
3,200+ NCLEX questions with think-like-a-nurse rationales, unfolding case studies and adaptive readiness exams. Start with free practice questions, then choose a plan when you are ready.
Create Account →